Surgical Management of Patients with Neuroendocrine Neoplasms of the Appendix: Appendectomy or More

Neuroendocrinology

Volumn 106, Issue 3, 2018, Pages 242-251

  Pawa, Nikhil ^a   Clift, Ashley K ^b   Osmani, Helai ^a   Drymousis, Panagiotis ^b   Cichocki, Andrzej ^c   Flora, Rashpal ^b   Goldin, Robert ^b   Patsouras, Dimitrios ^a   Baird, Alan ^d   Malczewska, Anna ^b,e   Kinross, James ^b   Faiz, Omar ^a   Antoniou, Anthony ^a   Wasan, Harpreet ^b   Kaltsas, Gregory A ^f   Darzi, Ara ^b   Cwikla, Jaroslaw B ^g   Frilling, Andrea ^b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d EALING HOSPITAL NHS TRUST   (United Kingdom)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f UNIVERSITY OF ATHENS   (Greece)

^g UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Appendectomy; Appendix; Hemicolectomy; Neoplasms; Neuroendocrine tumours

Indexed keywords

ANTINEOPLASTIC AGENT; SOMATOSTATIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; APPENDECTOMY; APPENDICEAL NEUROENDOCRINE NEOPLASM; APPENDIX TUMOR; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMICOLECTOMY; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MORBIDITY; NEUROENDOCRINE TUMOR; NORTH AMERICAN; OVERALL SURVIVAL; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR VOLUME; CANCER GRADING; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; LIVER TUMOR; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SECONDARY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APPENDECTOMY; APPENDICEAL NEOPLASMS; CHILD; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85021070990     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000478742     Document Type: Article

References (30)

1. Ellis L, Shale MJ, Coleman MP: Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol 2010;105: 2563-2569.
2. Lawrence B, Gustafsson BI, Chan A, et al: The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 2011;40: 1-18, vii.
3. Boudreaux JP, Klimstra DS, Hassan MM, et al: The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors. Pancreas 2010;39: 753-766.
4. Hauso O, Gustafsson BI, Kidd M, et al: Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008;113: 2655-2664.
5. Mullen JT, Savarese DMF: Carcinoid tumors of the appendix: a population-based study. J Surg Oncol 2011;104: 41-44.
6. SEER Data, 1973-2013. https://seer.cancer. gov/data/.
7. Yao JC, Hassan M, Phan A, et al: One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clin Oncol 2008;26: 3063-3072.
8. Pape U-F, Niederle B, Costa F, et al: ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas). Neuroendocrinology 2016;103: 144-152.
9. Pape U-F, Perren A, Niederle B, et al: ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology 2012;95: 135-156.
10. McGory ML, Maggard MA, Kang H, et al: Malignancies of the appendix: beyond case series reports. Dis Colon Rectum 2005;48: 2264-2271.
11. Grozinsky-Glasberg S, Alexandraki KI, Barak D, et al: Current size criteria for the management of neuroendocrine tumors of the appendix: are they valid? Clinical experience and review of the literature. Neuroendocrinology 2013;98: 31-37.
12. Alexandraki KI, Kaltsas GA, Grozinsky-Glasberg S, et al: Appendiceal neuroendocrine neoplasms: diagnosis and management. Endocr Relat Cancer 2016;23:R27-R41.
13. Bamboat ZM, Berger DL: Is right hemicolectomy for 2.0-cm appendiceal carcinoids justified? Arch Surg 2006;141: 349-352; discussion 352.
14. Rindi G, Klöppel G, Couvelard A, et al: TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007;451: 757-762.
15. Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A: AJCC Cancer Staging Manual (ed7). Chicago, IL: Springer 2010.
16. Dindo D, Demartines N, Clavien P-A: Classification of surgical complications: a new proposal with evaluation in a cohort of 6, 336 patients and results of a survey. Ann Surg 2004;240: 205-213.
17. Alexandraki KI, Griniatsos J, Bramis KI, et al: Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria. J Endocrinol Invest 2011;34: 255- 259.
18. O'Donnell ME, Carson J, Garstin WIH: Surgical treatment of malignant carcinoid tumours of the appendix. Int J Clin Pract 2007;61: 431-437.
19. Tchana-Sato V, Detry O, Polus M, et al: Carcinoid tumor of the appendix: a consecutive series from 1, 237 appendectomies. World J Gastroenterol 2006;12: 6699-6701.
20. Roggo A, Wood WC, Ottinger LW: Carcinoid tumors of the appendix. Ann Surg 1993;217: 385-390.
21. Stinner B, Kisker O, Zielke A, et al: Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World J Surg 1996;20: 183-188.
22. Kleiman DA, Finnerty B, Beninato T, et al: Features associated with metastases among well-differentiated neuroendocrine (carcinoid) tumors of the appendix: the significance of small vessel invasion in addition to size. Dis Colon Rectum 2015;58: 1137-1143.
23. Moertel CG, Dockerty MB, Judd ES: Carcinoid tumors of the vermiform appendix. Cancer 1968;21: 270-278.
24. Moertel CG, Weiland LH, Nagorney DM, et al: Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med 1987;317: 1699-1701.
25. Ciarrocchi A, Pietroletti R, Carlei F, et al: Propensity adjusted appraisal of the surgical strategy for appendiceal carcinoids. Tech Coloproctol 2015;19: 35-41.
26. de Lambert G, Lardy H, Martelli H, et al: Surgical management of neuroendocrine tumors of the appendix in children and adolescents: a retrospective French multicenter study of 114 cases. Pediatr Blood Cancer 2016;63: 598-603.
27. Steffen T, Ebinger SM, Warschkow R, et al: Long-term survival is not impaired after the complete resection of neuroendocrine tumors of the appendix. World J Surg 2015;39: 2670-2676.
28. Modlin IM, Frilling A, Salem RR, et al: Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies. Surgery 2015;159: 336-347.
29. Modlin IM, Kidd M, Latich I, et al: Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Ann Surg 2006;244: 52-60.
30. Goede AC, Caplin ME, Winslet MC: Carcinoid tumour of the appendix. Br J Surg 2003;90: 1317-1322.